J&J Staves Off Generic Topamax
A federal judge has sided with a Johnson & Johnson company in a patent infringement case over Topamax, keeping Mylan Laboratories Inc.'s generic version of the epilepsy drug off the shelf....To view the full article, register now.
Already a subscriber? Click here to view full article